Perioperative opioid | |||
---|---|---|---|
< 50 mcg/kg | > 50 mcg/kg | P value | |
n = 77 | n = 148 | ||
Female | 22 (29%) | 45 (30%) | 0.78 |
Age < 3years old | 2 (3%) | 25 (17%) | < 0.01 |
Race Black | 5 (7%) | 16 (11%) | 0.29 |
AHI > 20 (n=223) | 59 (77%) | 92 (62%) | <0.05 |
BMI for age > 99% (n=223) | 38 (50%) | 52 (35%) | < 0.05 |
PSG SO2 < 80 % (n=199) | 40 (56%) | 65 (51%) | 0.45 |
PSG EtCO2 > 60 mmHg (n=138) | 7 (15%) | 12 (13%) | 0.73 |
Craniofacial anomaly | 5 (7%) | 11 (7%) | 0.79 |
Neuromuscular disease | 8 (10%) | 21 (14%) | 0.42 |
Genetic syndrome | 56 (73%) | 35 (24%) | 0.55 |
Congenital heart disease | 68 (88%) | 15 (10%) | 0.72 |
Use of ketamine | 29 (38%) | 36 (24%) | < 0.05 |
Use of dexmedetomidine | 60 (78%) | 71 (48%) | <0.01 |
Neither dexmedetomidine nor ketamine | 11 (14%) | 60 (41%) | <0.01 |
Use of either dexmedetomidine or ketamine | 66 (86%) | 88 (60%) | <0.01 |
NSAIDs (ibuprofen or ketorolac) | 36 (47%) | 34 (23%) | < 0.01 |
Acetaminophen | 74 (96%) | 142 (96%) | >0.99 |
PICU admission | 52 (68%) | 76 (51%) | < 0.05 |
Anesthesia without opioid | 57 (74%) | 31 (21%) | <0.01 |
Surgery after 2013 (2014–2018) | 70 (91%) | 96 (65%) | <0.01 |